//Краткое руководство по ведению пациентов с онкологическими заболеваниями мочеполовой системы

120//

Литература

Ferlay J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359. https://www.ncbi.nlm.nih.gov/pubmed/25220842.

Incedence of oncological malignances in Russia in 2013. Pod red. A.D. Kaprina, V.V. Starinskogo, G.V. Petrovoi. M.: MNIOI im. P.A. Gertsena – filial FGBU «FMITs im. P.A. Gertsena» Minzdrava Rossii. 2015. (In Russ.)

Bell K.J. et al. Prevalence of incidental prostate cancer: A systematic review of autopsy studies. Int J Cancer. 2015;137:1749. https://www.ncbi.nlm.nih.gov/pubmed/25821151.

Jansson K.F. et al. Concordance of tumor differentiation among brothers with prostate cancer. Eur Urol. 2012;62:656. https://www.ncbi.nlm.nih.gov/pubmed/22386193.

Hemminki K. Familial risk and familial survival in prostate cancer. World J Urol. 2012;30:143. https://www.ncbi.nlm.nih.gov/pubmed/22116601.

Tan D.S. et al. Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography. J Clin Oncol. 2016;34:91. https://www.ncbi.nlm.nih.gov/pubmed/26578615.

Brierley A. et al. TNM classification of malignant tumors. UICC International Union Against Cancer. 8th edn. 20016. http://www.uicc.org/resources/tnm/publications-resources.

Epstein J.I. et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005;29:1228. https://www.ncbi.nlm.nih.gov/pubmed/16096414.

IARC France All Cancers (excluding non-melanoma skin cancer) Estimated Incidence, Mortality and Prevalence Worldwide in 2012. 2014. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.

Etzioni R. et al. Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening. Med Care. 2013;51:295. https://www.ncbi.nlm.nih.gov/pubmed/23269114.

//Краткое руководство по ведению пациентов с онкологическими заболеваниями мочеполовой системы

//121

Ilic D. et al. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;1:CD004720. https://www.ncbi.nlm.nih.gov/pubmed/23440794.

Hayes J.H. et al. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA. 2014;311:1143. https://www.ncbi.nlm.nih.gov/pubmed/24643604.

Andriole G.L. et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010;362:1192. https://www.ncbi.nlm.nih.gov/pubmed/20357281.

Thompson I.M. et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349:215. https://www.ncbi.nlm.nih.gov/pubmed/19297565.

Booth N. et al. Health-related quality of life in the Finnish trial of screening for prostate cancer. Eur Urol. 2014;65:39. https://www.ncbi.nlm.nih.gov/pubmed/23265387.

Vasarainen H. et al. Effects of prostate cancer screening on health-related quality of life: results of the Finnish arm of the European randomized screening trial (ERSPC). Acta Oncol. 2013;52:1615. https://www.ncbi.nlm.nih.gov/pubmed/23786174.

Heijnsdijk E.A. et al. Quality-of-life effects of prostate-specific antigen screening. N Engl J Med. 2012;367:595. https://www.ncbi.nlm.nih.gov/pubmed/22894572.

Richie J.P. et al. Effect of patient age on early detection of prostate cancer with serum prostatespecific antigen and digital rectal examination. Urology. 1993;42:365. https://www.ncbi.nlm.nih.gov/pubmed/7692657.

Carvalhal G.F. et al. Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less. J Urol. 1999;161:835. https://www.ncbi.nlm.nih.gov/pubmed/10022696.

Stamey T.A. et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 1987;317:909. https://www.ncbi.nlm.nih.gov/pubmed/2442609.

Catalona W.J. et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol. 1994;151:1283. https://www.ncbi.nlm.nih.gov/pubmed/7512659.